3D MRI-based tumor delineation of ocular melanoma and its comparison with conventional techniques.

The aim of this study is to (1) compare the delineation of the tumor volume for ocular melanoma on high-resolution three-dimensional (3D) T2-weighted fast spin echo magnetic resonance imaging (MRI) images with conventional techniques of A- and B-scan ultrasound, transcleral illumination, and placement of tantalum markers around tumor base and (2) to evaluate whether the surgically placed marker ring tumor delineation can be replaced by 3D MRI based tumor delineation. High-resolution 3D T2-weighted fast spin echo (3D FSE) MRI scans were obtained for 60 consecutive ocular melanoma patients using a 1.5 T MRI (GE Medical Systems, Milwaukee, WI), in a standard head coil. These patients were subsequently treated with proton beam therapy at the UC Davis Cyclotron, Davis, CA. The tumor was delineated by placement of tantalum rings (radio-opaque markers) around the tumor periphery as defined by pupillary transillumination during surgery. A point light source, placed against the sclera, was also used to confirm ring agreement with indirect ophthalmoscopy. When necessary, intraoperative ultrasound was also performed. The patients were planned using EYEPLAN software and the tumor volumes were obtained. For analysis, the tumors were divided into four categories based on tumor height and basal diameter. In order to assess the impact of high-resolution 3D T2 FSE MRI, the tumor volumes were outlined on the MRI scans by two independent observers and the tumor volumes calculated for each patient. Six (10%) of 60 patients had tumors, which were not visible on 3D MRI images. These six patients had tumors with tumor heights < or = 3 mm. A small intraobserver variation with a mean of (-0.22 +/- 4)% was seen in tumor volumes delineated by 3D T2 FSE MR images. The ratio of tumor volumes measured on MRI to EYEPLAN for the largest to the smallest tumor volumes varied between 0.993 and 1.02 for 54 patients. The tumor volumes measured directly on 3D T2 FSE MRI ranged from 4.03 to 0.075 cm3. with a mean of 0.87 +/- 0.84 cm3. The tumor shapes obtained from 3D T2 FSE MR images were comparable to the tumor shapes obtained using EYEPLAN software. The demonstration of intraocular tumor volumes with the high-resolution 3D fast spin echo T2 weighted MRI is excellent and provides additional information on tumor shape. We found a high degree of accuracy for tumor volumes with direct MRI volumetric measurements in uveal melanoma patients. In some patients with extra large tumors, the tumor base and shape was modified, because of the additional information obtained from 3D T2 FSE MR images.

[1]  E. Richtig,et al.  Calculated tumour volume as a prognostic parameter for survival in choroidal melanomas , 2004, Eye.

[2]  M. G. Sabini,et al.  Clinical Application of Proton Beams in the Treatment of Uveal Melanoma: The First Therapies Carried Out in Italy and Preliminary Results (Catana Project) , 2003, Tumori.

[3]  D Barash,et al.  Use of high-frequency ultrasound imaging to improve delineation of anterior uveal melanoma for proton irradiation. , 2001, Physics in medicine and biology.

[4]  Ann Schalenbourg,et al.  Eye retention after proton beam radiotherapy for uveal melanoma. , 2003, International journal of radiation oncology, biology, physics.

[5]  B. Hershey,et al.  Intraocular tumors: evaluation with MR imaging. , 1988, Radiology.

[6]  Jerry D. Slater,et al.  Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality. , 2001, International journal of radiation oncology, biology, physics.

[7]  P. K. Jensen,et al.  Ultrasonographic three‐dimensional scanning for determination of intraocular tumour volume , 1992, Acta ophthalmologica.

[8]  J. B. Bond,et al.  MR imaging of malignant uveal melanoma: role of pulse sequence and contrast agent. , 1991, AJNR. American journal of neuroradiology.

[9]  Lynn J. Verhey,et al.  New UCSF proton ocular beam facility at the Crocker Nuclear Laboratory Cyclotron (UC Davis) , 1996 .

[10]  R. Dendale,et al.  Résultats du traitement du mélanome de la choroïde par faisceau de protons , 2002 .

[11]  R. Goldberg,et al.  Primary orbital extraskeletal ewing sarcoma. , 2003, Archives of ophthalmology.

[12]  M Goitein,et al.  Planning proton therapy of the eye. , 1983, Medical physics.

[13]  E. Gragoudas,et al.  Intraocular recurrence of uveal melanoma after proton beam irradiation. , 1992, Ophthalmology.

[14]  T. Phillips,et al.  Uveal Melanoma: Growth Rate and Prognosis , 1997 .

[15]  R Goodall,et al.  The 62 MeV proton beam for the treatment of ocular melanoma at Clatterbridge. , 1993, The British journal of radiology.

[16]  J. O'Brien,et al.  High-resolution 3D T2-weighted fast spin echo: new applications in the orbit , 2003, Neuroradiology.

[17]  G. Peyman,et al.  Magnetic resonance imaging in the evaluation and differentiation of uveal melanoma. , 1987, Ophthalmology (Rochester, Minn.).

[18]  J. O'Brien,et al.  Three-dimensional high-resolution magnetic resonance imaging of ocular and orbital malignancies. , 2002, A M A Archives of Ophthalmology.

[19]  A. Courdi,et al.  [The Center for Proton Therapy in Nice. GRASE (Group de Radiothérapie Sud-Europe)]. , 1993, Pathologie-biologie.

[20]  L. Verhey,et al.  Anterior segment sparing to reduce charged particle radiotherapy complications in uveal melanoma. , 1997, International journal of radiation oncology, biology, physics.

[21]  E. Gragoudas,et al.  Tumor basal area and metastatic death after proton beam irradiation for choroidal melanoma. , 2003, Archives of ophthalmology.

[22]  T. Phillips,et al.  Newer Radiation Modalities for Choroidal Tumors , 2006, International ophthalmology clinics.

[23]  P Gastaud,et al.  Results of proton therapy of uveal melanomas treated in Nice. , 1999, International journal of radiation oncology, biology, physics.

[24]  J. Castro,et al.  Results of heavy ion radiotherapy , 1995, Radiation and environmental biophysics.

[25]  J. Caudrelier,et al.  MRI definition of target volumes using fuzzy logic method for three-dimensional conformal radiation therapy. , 2003, International journal of radiation oncology, biology, physics.